Corporate Compliance

Integrity is embedded in our company culture. Our commitment to ethics and good corporate citizenship is grounded in our compliance with laws and regulations that govern the way we develop novel drug candidates to address the needs of patients with immuno-inflammatory diseases who lack satisfactory treatment options.

Company policies are continually evolving to include updates and changes to laws, regulations, and codes impacting the pharmaceutical industry, as well as to incorporate internal policy improvements.

Our compliance program incorporates elements of an effective compliance program in accordance with the "Compliance Program Guidance for Pharmaceutical Manufacturers", developed by the U.S. Department of Health and Human Services, Office of Inspector General.

The Aclaris Compliance Program is designed to:

  • Prevent, detect, and correct violations of law and company policies and procedures.
  • Ensure the establishment of compliance-related policies and procedures for business operations.
  • Ensure development of training and other programs designed to educate employees regarding applicable policies, regulations, and codes.
  • Implement a mechanism to evaluate the effectiveness of essential elements of the compliance program.
  • Ensure appropriate corrective action is taken to prevent recurrence of misconduct.